Chow J
Med Sci (Basel). 2024; 12(4).
PMID: 39584917
PMC: 11586987.
DOI: 10.3390/medsci12040067.
Liu C, Jiang W, Sun J, Cui J, He D, Cheng S
J Hepatocell Carcinoma. 2024; 11:2283-2292.
PMID: 39582815
PMC: 11586121.
DOI: 10.2147/JHC.S491733.
Zhu C, Guyer G, Bertholet J, Mueller S, Loebner H, Volken W
Med Phys. 2024; 52(1):489-503.
PMID: 39460998
PMC: 11700002.
DOI: 10.1002/mp.17467.
Fodil N, Abdelhakem M, Yahia G, Ammar H
Asian Pac J Cancer Prev. 2024; 25(7):2467-2474.
PMID: 39068581
PMC: 11480600.
DOI: 10.31557/APJCP.2024.25.7.2467.
Mohammadi M, Banisharif S, Moradi F, Zamanian M, Tanzifi G, Ghaderi S
Rep Pract Oncol Radiother. 2024; 28(6):823-834.
PMID: 38515826
PMC: 10954263.
DOI: 10.5603/rpor.98728.
Artificial general intelligence for radiation oncology.
Liu C, Liu Z, Holmes J, Zhang L, Zhang L, Ding Y
Meta Radiol. 2024; 1(3).
PMID: 38344271
PMC: 10857824.
DOI: 10.1016/j.metrad.2023.100045.
Comparison of the Effectiveness of Radiotherapy with 3D-CRT, IMRT, VMAT and PT for Newly Diagnosed Glioblastoma: A Bayesian Network Meta-Analysis.
Xu S, Frakulli R, Lin Y
Cancers (Basel). 2023; 15(23).
PMID: 38067401
PMC: 10705506.
DOI: 10.3390/cancers15235698.
Intensity-modulated radiotherapy for cushing's disease: single-center experience in 70 patients.
Lian X, Xu Z, Sun S, Wang W, Zhu H, Lu L
Front Endocrinol (Lausanne). 2023; 14:1241669.
PMID: 37822603
PMC: 10562628.
DOI: 10.3389/fendo.2023.1241669.
Technical note: A collision prediction tool using Blender.
Guyer G, Mueller S, Wyss Y, Bertholet J, Schmid R, Stampanoni M
J Appl Clin Med Phys. 2023; 24(11):e14165.
PMID: 37782250
PMC: 10647990.
DOI: 10.1002/acm2.14165.
Three Discipline Collaborative Radiation Therapy (3DCRT) special debate: Radiation oncology has become so technologically complex that basic fundamental physics should no longer be included in the modern curriculum for radiation oncology residents.
Beriwal S, Corrigan K, McDermott P, Ryckman J, Tsao M, Zheng D
J Appl Clin Med Phys. 2023; 24(9):e14128.
PMID: 37606366
PMC: 10476972.
DOI: 10.1002/acm2.14128.
Assessment of dosimetric impact of interfractional 6D setup error in tongue cancer treated with IMRT and VMAT using daily kV-CBCT.
Shinde P, Jadhav A, Shankar V, Dhoble S
Rep Pract Oncol Radiother. 2023; 28(2):224-240.
PMID: 37456705
PMC: 10348325.
DOI: 10.5603/RPOR.a2023.0020.
Simultaneous dose distribution and fluence prediction for nasopharyngeal carcinoma IMRT.
Li Y, Cai W, Xiao F, Zhou X, Cai J, Zhou L
Radiat Oncol. 2023; 18(1):110.
PMID: 37403141
PMC: 10320945.
DOI: 10.1186/s13014-023-02287-4.
Lattice position optimization for LATTICE therapy.
Zhang W, Lin Y, Wang F, Badkul R, Chen R, Gao H
Med Phys. 2023; 50(12):7359-7367.
PMID: 37357825
PMC: 11058082.
DOI: 10.1002/mp.16572.
Dosimetric Comparison of Hypofractionated Regimen in Breast Cancer Using Two Different Techniques: Intensity-Modulated Radiation Therapy (IMRT) and Volumetric-Modulated Arc Therapy (VMAT).
Prasun P, Kharade V, Pal V, Gupta M, Das S, Pasricha R
Cureus. 2023; 15(4):e38045.
PMID: 37228558
PMC: 10206676.
DOI: 10.7759/cureus.38045.
Beam angle optimization for proton therapy via group-sparsity based angle generation method.
Shen H, Zhang G, Lin Y, Rotondo R, Long Y, Gao H
Med Phys. 2023; 50(6):3258-3273.
PMID: 36965109
PMC: 10272076.
DOI: 10.1002/mp.16392.
Application of individualized multimodal radiotherapy combined with immunotherapy in metastatic tumors.
Ji X, Jiang W, Wang J, Zhou B, Ding W, Liu S
Front Immunol. 2023; 13:1106644.
PMID: 36713375
PMC: 9877461.
DOI: 10.3389/fimmu.2022.1106644.
Feasibility of a multigroup Boltzmann-Fokker-Planck solution for electron beam dose calculations.
Naceur A, Hebert A, Romano P, Forget B, Chilian C, Carrier J
Sci Rep. 2023; 13(1):1310.
PMID: 36693824
PMC: 9873679.
DOI: 10.1038/s41598-023-27376-y.
Quality assurance assessment of intra-acquisition diffusion-weighted and T2-weighted magnetic resonance imaging registration and contour propagation for head and neck cancer radiotherapy.
Naser M, Wahid K, Ahmed S, Salama V, Dede C, Edwards B
Med Phys. 2022; 50(4):2089-2099.
PMID: 36519973
PMC: 10121748.
DOI: 10.1002/mp.16128.
Treatment plan prescreening for patient-specific quality assurance measurements using independent Monte Carlo dose calculations.
Xu Y, Zhang K, Liu Z, Liang B, Ma X, Ren W
Front Oncol. 2022; 12:1051110.
PMID: 36419878
PMC: 9676489.
DOI: 10.3389/fonc.2022.1051110.
An independent Monte Carlo-based IMRT QA tool for a 0.35 T MRI-guided linear accelerator.
Khan A, Simiele E, Lotey R, DeWerd L, Yadav P
J Appl Clin Med Phys. 2022; 24(2):e13820.
PMID: 36325743
PMC: 9924112.
DOI: 10.1002/acm2.13820.
